XIENCE™ Family of Drug-Eluting Stents - Abbott Cardiovascular
WEBXIENCE drug-eluting stents (DES), the world's leading DES, has the lowest rates of late stent thrombosis and unparalleled performance, even in complex patients.
Intracoronary stents: Stent types - UpToDate
WEBFeb 7, 2023 · For most patients undergoing percutaneous coronary intervention with stenting, current-generation drug-eluting stents (DES) are preferred to bare metal stents due to a significantly lower risk of the need for target vessel revascularization.
Drug-eluting stent - Wikipedia
WEBA Drug-Eluting Stent (DES) is a small mesh tube that is placed in the arteries to keep them open in the treatment of vascular disease. The stent slowly releases a drug to block cell proliferation, thus preventing the arterial narrowing that can occur after stent implantation.
Coronary Stents - Boston Scientific
WEBPromus ELITE™ Everolimus-Eluting Platinum Chromium Coronary Stent System. Outstanding Acute Performance. Proven Long-Term Outcomes.
What Are Drug-Eluting Stents? Risks, Benefits and More - WebMD
WEBFeb 11, 2024 · A drug-eluting stent, or DES, is a small, metal mesh tube placed in a blocked coronary artery. The metal is coated in medicine and helps reopen your artery and keep it open. Stents are used...
Eluvia™ Drug-Eluting Vascular Stent System - Boston Scientific
WEBSee what physicians are saying about the unprecedented clinical outcomes for the Eluvia Drug-Eluting Stent, including two-year primary patency and TLR rates. Eluvia provides consistent, durable outcomes in challenging SFA disease and features a polymer design for controlled drug release.
Drug-Eluting Coronary-Artery Stents - The New England Journal of Medicine
WEBJan 17, 2013 · Progress in polymer technology has been aimed at decreasing local inflammatory reactions and thrombosis by improving the biocompatibility of polymers. 17,18 Drug-eluting stents that have been...
Coronary Drug-Eluting Stent - Medscape
WEBJun 20, 2022 · Drug-eluting stents (DES) are a standard metallic coronary stent with a polymer coating and an antiproliferative drug, which allows drug elution into the coronary wall for weeks to months...
New Drug-Eluting Stents | Circulation: Cardiovascular Interventions
WEBAug 1, 2010 · Drug-eluting stents (DES)were primarily conceived to reduce in-stent neointimal formation and therefore minimize the occurrence of restenosis, the major drawback of percutaneous coronary interventions with bare-metal stents (BMS).
Drug-Eluting Stents - U.S. Pharmacist
WEBFeb 17, 2012 · Percutaneous coronary intervention (PCI) involves both nonstent and stent procedures. While bare-metal stents (BMS) are still utilized, drug-eluting stents (DES) now offer clinicians the ability to prevent restenosis via a different mechanism.
Skip to content